News

If you feel healthy, it’s easy to think colorectal cancer screening can wait; Many people do. But the truth is, screening is one of the most effective ways to prevent colon cancer or find it early, when it’s easiest to treat. A colonoscopy, the gold standard of colorectal cancer screenings, is also one of the few cancer screenings that can help prevent cancer. Gastroenterologists can remove polyps during screening that could later lead to cancer. Let’s clear up some common myths that keep peop...

Dan Austin, a stage IV colorectal cancer survivor, shared his story with The Detroit News. Now 45 years old, he was diagnosed in 2024, right before he would be eligible by his insurance to begin colorectal cancer screenings. Najeeb Al Hallak, M.D., MS , medical oncologist and co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team (MDT) at Karmanos, briefly gave an update on how Austin is doing and explained how Karmanos takes care of the entire patient when they ...

The Barbara Ann Karmanos Cancer Institute ’s Office of Community Outreach and Engagement (COE) announces the 2026 Community Conversations on Cancer . This is the second year Karmanos has partnered with the Detroit Public Library to present the series. The sessions are held in person at the Main Branch, located at 5201 Woodward Avenue (Detroit, MI 48202) and virtually via Zoom, from 6 -7 p.m. The virtual option allows people from across the state to attend. The first three sessions cover colorectal cance...

Hyeong-Reh C. Kim, Ph.D., professor of Pathology and Oncology, has been appointed vice dean of Research for the Wayne State University (WSU) School of Medicine. Dr. Kim, who is a member of the Tumor Biology and Microenvironment Research Program at the Barbara Ann Karmanos Cancer Institute, is a nationally respected scientist, educator and institutional leader with more than three decades of distinguished service to WSU. “Dr. Kim brings an exceptional combination of scientific excellence, strategic visio...

WMYD TV20 On the last day of National Cancer Prevention Month in February, Boris Pasche, M.D., Ph.D., FACP, CEO and president of the Barbara Ann Karmanos Cancer Institute, joined the Home Health Care Today Show to discuss cancer screenings. Dr. Pasche was joined by Jenni Beamer, senior executive director of the American Cancer Society in Michigan. Watch the show here .

For the third consecutive year, George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, was again listed on  Becker’s Hospital Review’s Hospital and Health System Chief Medical Officers to Know . The 2026 list includes over 250 CMOs nationwide who are steadfast advocates for patient safety, trusted liaisons between medical staff and executive leadership and powerful catalysts for meaningful change. The named CMOs are leaders elevating standards through innovative quality-i...

The Barbara Ann Karmanos Cancer Institute is partnering with Wayne State University (WSU) School of Medicine and three athletic facilities to offer cancer survivors 12 weeks of exercise classes focused on building strength and improving overall fitness. These free classes are provided as part of an exercise program and interventional trial called CrossFit® and Physical Activity: A Better Life Experience (CAPABLE), which introduces cancer survivors to the sport of CrossFit®. Below are the sessions schedu...

Hearing the words “you have cancer” can feel like the ground has shifted beneath you. Even before treatment begins, many people experience fear, worry, sadness, or a sense of being overwhelmed. Appointments, test results, side effects, and changes to daily life can take an emotional toll. While family and friend support is incredibly important, it’s okay to need more. Taking care of your mental and emotional health is a meaningful part of healing. At Karmanos Cancer Institute locations across McLaren He...

MD/alert Suresh Balasubramanian, M.D. , hematologist and medical oncologist, and member of the  Hematology Oncology  and  Multiple Myeloma and Amyloidosis  Multidisciplinary Teams at Karmanos, discussed the latest survival data from the PATHFINDER study, investigating the use of the targeted inhibitor KIT D816V. He explained how this therapy has transformed the treatment of systemic mastocytosis. Watch the interview here .

A research project conducted by Lauren Hamel, Ph.D., MBA, was selected for the first round of internal funding for Wayne State University’s (WSU) Grand Challenges research program. Dr. Hamel, co-leader of the  Population Studies (PS) Research Program  at the  Barbara Ann Karmanos Cancer Institute  and associate professor of Oncology at WSU School of Medicine, received a Seed Grant award for “AI-Driven Modeling of Cancer Care Communication and Outcome Patterns to Advance Health Equity...